Effect of fructooligosaccharide containing enteral formulas on subjective tolerance factors, serum chemistry profiles, and faecal bifidobacteria in healthy adult male subjects

Microbial Ecology in Health and Disease

Volumn 9, Issue 6, 1996, Pages 279-285

  Garleb, K A ^a   Snook, J T ^b   Marcon, M J ^c   Wolf, B W ^a   Johnson, W A ^b  

^a ABBOTT LABORATORIES   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

bifidobacteria; enteral formula; fructooligosaccharide; tolerance

Indexed keywords

MICROBIOTA;

EID: 0030426320     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1234-987X(199611)9:6<279::AID-MEH440>3.3.CO;2-W     Document Type: Article

References (28)

1. Becker R, Lorenz K, Saunders RM. (1977). Saccharides of maturing triticale, wheat and rye. Journal of Agricultural Food Chemistry 25, 1115-1118.
2. Biavati B, Sgorbati B, Scardovi V. (1992). The genus bifidobacterium. In: Balows A, Triipes HG, Dworkin M, Harder W, Schleifer KH (eds) The Prokaryotes: A Handbook on the Biology of Bacteria, 2nd edn. Springer-Verlag, pp. 816-833.
3. Briet F, Achour L, Flourié B, Beaugerie L, Pellier P, Franchisser C, Bornet F, Rambaud J-C. (1995). Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly. European Journal Clinical Nutrition 49, 501-507.
4. Clevenger MA, Turnbull D, Inoue H, Enomoto M, Allen J, Henderson L, Jones E. (1988). Toxicological evaluation of neosugar: Genotoxicity, carcinogenicity, and chronic toxicity. Journal of the American College of Toxicology 7, 643-662.
5. Darbyshire B, Henry RJ. (1981). Differences in fructan content and synthesis in some Allium species. New Phytologist 82, 249-256.
6. Hata Y, Hara T, Oikawa T, Yamamoto M, Hirose N, Nagashima T, Torihama N, Nakajima K, Watabe A, Yamashita M. (1983). Effects of fructooligosaccharides (Neosugar) on hyperlipidemia. Geriatric Medicine 21, 156-167.
7. Hata Y, Nakajima K. (1985). Studies on relationship between intake of fructooligosaccharides and abdominal symptoms - Estimation of maximum non-effective dose and 50% laxative effective dose. Geriatric Medicine 23, 817-828.
8. Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. (1986). Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria and Microflora 5, 37-50.
9. Hidaka H, Hirayama M, Yamada K. (1991). Fructooligosaccharide enzymatic preparation and biofunction. Journal of Carbohydrate Chemistry 10, 509-522.
10. Homma N. (1988). Bifidobacteria as a resistance factor in human beings. Bifidobacteria and Microflora 7, 35-43.
11. Hosoya N, Dhorranintra B, Hidaka H. (1988). Utilization of [U-14C] fructooligosaccharides in man as energy resources. Journal of Clinical Biochemistry and Nutrition 5, 67-74.
12. May T, Mackie RI, Fahey GC Jr, Cremin JC, Garleb KA. (1994). Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scandinavian Journal of Gastroenterology 19, 916-922.
13. Mitsuoka T. (1982). Recent trends in research on intestinal flora. Bifidobacteria and Microflora 1, 3-24.
14. Mitsuoko T, Hidaka H, Eida T. (1987). Effect of fracto-oligosaccharides on intestinal microflora. Die Nahrung 31, 427-436.
15. Mitsuoko T, Kaneuchi C. (1977). Ecology of the bifidobacteria. American Journal of Clinical Nutrition 30, 1799-1810.
16. Modler HW, McKellar RC, Yaguchi M. (1990). Bifidobacteria and bifidogenic factors. Canadian Institute of Food Science and Technology Journal 23, 29-41.
17. Munoa FJ, Pares R. (1988). Selective medium for isolation and enumeration of Bifidobacterium spp. Applied and Environmental Microbiology 54, 1715-1718.
18. Nash P, Krenz M. (1991). Culture media. In: Balows A (ed) Manual of Clinical Microbiology, 5th edn. American Society of Microbiology, Washington, DC, pp. 1226-1288.
19. Oku T, Tokunaga T, Hosoya N. (1984). Non-digestibility of a new sweetener, "Neosugar", in the rat. Journal of Nutrition 114, 1574-1581.
20. Palmquist DL, Conrad HR. (1978). High fat rations for dairy cows. Effects on feed intake, milk and fat production and plasma metabolites. Journal of Dairy Science 61, 890-901.
21. Scardovi V. (1986). Bifidobacterium. In: Sneath PH, Mair NS, Sharpe ME, Holt J (eds) Bergey's Manual of Systemic Bacteriology 1st edn, Vol II, Williams and Wilkins Publishers, Baltimore, MD, pp. 1418-1434.
22. Shiomi N, Izawa M. (1980). Purification and characterization of sucrose-sucrose 1-fructosyltransferase from the roots of asparagus. Agricultural and Biological Chemistry 44, 603-614.
23. Stone-Dorshow T, Levitt MD. (1987). Gaseous response to ingestion of a poorly absorbed fructooligosaccharide sweetener. American Journal of Clinical Nutrition 46, 61-65.
24. Tissier H. (1900) Recherches sur la flore intestinale des nourrissons (etat normal et pathologique), These de medecine de l'Universite de Paris.
25. Tokunaga T, Oku T, Hosoya N. (1986). Influence of chronic intake of new sweetener fructooligosaccharide (Neosugar) on growth and gastrointestinal function of the rat. Journal of Nutritional Science and Vitaminology 32, 111-121.
26. Tokunaga T, Oku T, Hosoya N. (1989). Utilization and excretion of a new sweetener, fructooligosaccharide (Neosugar), in rats. Journal of Nutrition 119, 553-559.
27. Williams CH, Witherly SA, Buddington RK. (1994). Influence of dietary neosugar on selected bacterial groups of the human faecal microbiota. Microbial Ecology in Health and Disease 7, 91-97.
28. Wolf BW, Titgemeyer EC, Fahey GC, Garleb KA. (1994). Fermentability of selected oligosaccharides. The FASEB Journal 8, A186.